TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)
A phase 1/2 trial of Vepdegestrant and Abemaciclib in advanced solid tumours, run by Pfizer, active and no longer recruiting.
Overview
TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A) is a phase 1/2 interventional study registered as NCT05548127 by Pfizer, with 37 participants enrolled, started 2023-02-23 and due to reach its primary completion in 2027-03-24. Interventions recorded: ARV-471 and Abemaciclib.
Similar pages
not linked directly; found by shared links- TrialVepdegestrant (ARV-471/PF-07850327) + Palbociclib vs Letrozole + Palbociclib in ER(+)/HER2(-) Advanced Breast Cancer
Shares Vepdegestrant, Pfizer (incl. Seagen), Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialTACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B)
Shares Vepdegestrant, Pfizer (incl. Seagen), Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.
Shares Vepdegestrant, Pfizer (incl. Seagen), Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialTACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)
Shares Vepdegestrant, Pfizer (incl. Seagen), Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialEvaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Shares Abemaciclib, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
Shares Pfizer (incl. Seagen), Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of Abemaciclib (LY2835219) in Participants With Breast Cancer
Shares Abemaciclib, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer
Shares Abemaciclib, Metastatic cancer (cancer that has spread) and the tag pipeline.